Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Net Income towards Common Stockholders (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Net Income towards Common Stockholders data on record, last reported at -$18.1 million in Q3 2025.

  • For Q3 2025, Net Income towards Common Stockholders rose 37.21% year-over-year to -$18.1 million; the TTM value through Sep 2025 reached -$47.0 million, up 10.03%, while the annual FY2023 figure was $12.3 million, 244.51% up from the prior year.
  • Net Income towards Common Stockholders reached -$18.1 million in Q3 2025 per SNTI's latest filing, down from -$14.7 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $21.7 million in Q3 2023 and bottomed at -$28.9 million in Q3 2024.
  • Average Net Income towards Common Stockholders over 5 years is -$7.9 million, with a median of -$8.0 million recorded in 2023.
  • Peak YoY movement for Net Income towards Common Stockholders: plummeted 997692.87% in 2022, then skyrocketed 1028.2% in 2023.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$3.9 million in 2021, then crashed by 306.16% to -$15.7 million in 2022, then skyrocketed by 99.82% to -$28000.0 in 2023, then tumbled by 102992.86% to -$28.9 million in 2024, then surged by 37.21% to -$18.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$18.1 million in Q3 2025, -$14.7 million in Q2 2025, and -$14.1 million in Q1 2025.